| Pharmaceutical active ingredients: |
| Fusobacterium Necrophorum Bacterin |
| Available forms, composition and doses of Fusogard: |
| Injectable; Injection; Fusobacterium Necrophorum Bacterin |
| Fusogard medical category: |
| Veterinary; Pet Meds:Cattle / Calves |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fusycom | Fusidic Acid; Sodium Fusidate | Combiphar |
| Futaderm | Fusidic Acid; Sodium Fusidate | Interbat |
| Futasole | Fusidic Acid; Sodium Fusidate | Gulf Pharmaceutical Industries, Julphar |
| Hopaq | Fusidic Acid; Sodium Fusidate | Hoe Pharmaceuticals; Metro Drug Distribution; New Marketlink Pharmaceutical Corporation |
| Tibicorten F | Fusidic Acid; Triamcinolone Benetonide | Stiefel Laboratories; Sigma-Tau Pharmaceuticals |
| Alkalovert | Fytic Acid | Dr. Gustav Klein |
| Alkovert | Fytic Acid | Unidentified Pharmaceutical Company |
| Obagi Nu-Derm Exfoderm | Fytic Acid | Obagi Medical Products; Zoe Nissi |
| Phytat | Fytic Acid (Fytate Sodium) | Tradiphar Laboratoire |
| Phytat D.B. | Fytic Acid (Fytate Sodium) | Marx Laboratoire |